DailyDoctor Archive Specialties Get app
Back to the 13 September 2026 edition

Research · 04 of 06

Interval training matched standard pulmonary rehabilitation in fibrotic lung disease

Interval training is a safe alternative in fibrotic interstitial lung disease, but it is not a better one.

Design
randomised controlled trial, stratified by exertional desaturation, intention-to-treat linear mixed models
Population
131 participants with fibrotic interstitial lung disease in an 8-week, twice-weekly rehabilitation programme
Primary outcome
cycle endurance time after pulmonary rehabilitation
Effect
mean difference −63 s (95% CI −195 to 68); 6-minute walk distance 4 m (−20 to 28); no adverse events

Pulmonary rehabilitation is guideline-recommended in interstitial lung disease, and a proportion of participants get no meaningful benefit — which has prompted the argument that the standard moderate continuous training protocol may not be the right exercise stimulus for fibrotic disease. This trial tested that directly. It randomised 131 participants with fibrotic interstitial lung disease, stratified by exertional desaturation above or below 90%, to high-intensity interval training or standard moderate continuous training within an otherwise unchanged eight-week, twice-weekly programme.

Both groups achieved clinically important improvement in cycle endurance time, the primary outcome, with no difference between them (mean difference −63 seconds, 95% CI −195 to 68). Six-minute walk distance was likewise indistinguishable (4 m, −20 to 28), as were symptoms, quality of life, skeletal muscle measures and physical activity. There were no adverse events in either arm, and similar proportions completed the programme and achieved the prescribed intensity and progression.

A well-conducted negative trial is useful in two directions. It closes off the idea that interval training is the missing ingredient for non-responders, and it opens up interval training as a legitimate alternative for people who prefer it or tolerate it better — including, notably, patients who desaturate, who were stratified rather than excluded.

  • Offer interval training as an alternative where a patient prefers it, not as an upgrade
  • Do not switch non-responders to interval training expecting a different result
  • Note that patients with exertional desaturation were included and stratified, not excluded
  • Both arms improved — the message is about which protocol, not whether to refer
  • Continue to refer every patient with fibrotic interstitial lung disease for rehabilitation

Why it matters

It closes a plausible explanation for why some patients gain nothing from pulmonary rehabilitation.

The statistics, in plain English

The mean difference of −63 seconds has a confidence interval from −195 to 68 that comfortably includes zero, so this is a genuine no-difference result rather than an underpowered one — though with 131 participants a modest true difference could still hide inside that interval. The more useful observation is that both groups improved by a clinically important amount, which means this compares two effective protocols rather than testing whether rehabilitation works. Equal completion and progression rates matter too: interval training was not harder to stick to.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

asthmacopdlungtransplantildsleep

Tomorrow morning, before your first patient

One edition a day for pulmonology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app